@FiercePharma: Roche resolves patent war with India's Glenmark over generic Tarceva. More | Follow @FiercePharma
@EricPFierce: 18 months after the #FDA slapped Cadila with a Form 483, it sends a warning letter. News | Follow @EricPFierce
@CarlyHFierce: ICYMI: Shire could nab Baxalta for $32B this week: Bloomberg. Story | Follow @CarlyHFierce
> Sources say that China's Jiangsu Hansoh Pharmaceutical is planning a Hong Kong IPO that could raise up to $3 billion. Story
> Pershing Square Holdings, one of the funds overseen by investor Bill Ackman, ended the year down 20.5% after its investment in Valeant Pharmaceuticals ($VRX) contracted significantly last year. Story
> A new study has found that shortages of emergency room drugs, many lifesaving, quadrupled in the U.S. between 2001 and 2014. Story
Medical Device News
@FierceMedDev: NIH backs smartphone-based artificial pancreas trials with almost $13M. More | Follow @FierceMedDev
@EmilyWFierce: Pathway Genomics scores $40M in Series E round for genetic test development. Story | Follow @EmilyWFierce
@VarunSaxena2: ICYMI: Scottish researchers develop ingestible 'pill camera' that images non-visible light to detect cancer. More | Follow @VarunSaxena2
> FDA cracks down on transvaginal mesh devices amid safety concerns. More
> Pathway Genomics scores $40M in Series E round for genetic test development. Article
Biotech News
@FierceBiotech: The scoop on every new drug approved in 2015. Feature | Follow @FierceBiotech
@JohnCFierce: Annapurna adds three new gene therapy programs from Ron Crystal's lab at Weill Cornell. Story | Follow @JohnCFierce
@DamianFierce: I cannot prove that OncoCyte got its name from this generator, but I will take credit anyway. Website | Follow @DamianFierce
> Report: Chinese biopharma Jiangsu Hansoh eyes a $3B IPO. Story
> Gilead lines up for a fast FDA OK with its next-gen hep C combo. More
Pharma Manufacturing News
> Cadila to buy Zoetis animal drugs and feed plant in India for $29M. Item
> FDA slaps two Cadila facilities with warning letters. More
> Orchid gets favorable report for its formulation facility near Chennai. Story
> Reuters: J&J shopping its Noramco API unit for up to $800M deal. News
> FDA unveils new pharma manufacturing program as part of draft guidance. More
Drug Delivery News
> Clearside announces positive Phase II results in win for back-of-the-eye drug delivery. Story
> Halozyme picks up $150M credit deal on its Roche, Baxalta royalties. More
> Amgen partners with Unilife on wearable injectors, may buy 20% stake in the struggling company. Article
> UCSB team makes toxic transdermal drugs safer with salt formulation. News
> FDA approves nonalcoholic formulation of cancer drug, eliminating risk of intoxication following treatment. More
Pharma Asia News
> Japan's push on innovative drugs gets a budget boost. More
> India's hep C market sets a global pace on cost, access. Report
> Indonesia pharma investment cap eyed as top firms plan new plants. Story
> Sinovac gets China FDA new drug, production nod for HFMD vaccine. Article
> EU and India set Jan. 18 date for talks on GVK drug ban. Item